LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)
Stock Stats
News
Legend Biotech (LEGN) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".
Legend Biotech Q4 Earnings Call Highlights [Yahoo! Finance]
Legend Biotech (LEGN) had its price target lowered by Morgan Stanley from $50.00 to $49.00. They now have an "overweight" rating on the stock.
Legend Biotech (LEGN) had its price target lowered by Royal Bank Of Canada from $66.00 to $62.00. They now have an "outperform" rating on the stock.
Legend Biotech (LEGN) was given a new $70.00 price target by Truist Financial Corporation.
Form 20-F Legend Biotech Corp For: Dec 31
Form 6-K Legend Biotech Corp For: Mar 10
Form 6-K Legend Biotech Corp For: Feb 06
Form SCHEDULE 13G/A Legend Biotech Corp Filed by: FMR LLC
Form 6-K Legend Biotech Corp For: Jan 23
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.